References
- Mandell CH, Garrett WS, Onderdonk AB , Bennett JE, Dolin R, Blaser MJ. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and other medically important anaerobic Gram-negative bacilli). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 2015; Philadelphia, PA: Elsevier, Saunders. 2773–80. 8th ed.
- Brazier JS, Hall V, Yusuf E, Duerden BI. Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol. 2002; 51: 269–72. [PubMed Abstract].
- Manson McGuire A, Cochrane K, Griggs AD, Haas BJ, Abeel T, Zeng Q, etal. Evolution of invasion in a diverse set of Fusobacterium species. MBio. 2014; 5: e01864. [PubMed Abstract] [PubMed CentralFull Text].
- Pett E, Saeed K, Dryden M. Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection. 2014; 42: 363–70. [PubMed Abstract].
- Hagelskjaer Kristensen L, Prag J. Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study. Eur J Clin Microbiol Infect Dis. 2008; 27: 733–9. [PubMed Abstract].
- Kristensen LH, Jensen A, Prag J. [Fusobacterium necrophorum: from tonsillitis to Lemierre's syndrome]. Ugeskr Laeger. 2009; 171: 987–90. [PubMed Abstract].
- Kisser U, Gurkov R, Flatz W, Berghaus A, Reichel O. Lemierre syndrome: a case report. Am J Otolaryngol. 2012; 33: 159–62. [PubMed Abstract].
- Johannesen K, Bodtger U, Heltberg O. Lemierre's syndrome: the forgotten disease. J Thromb Thrombolysis. 2014; 37: 246–8. [PubMed Abstract].
- Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis. 2000; 31: 524–32. [PubMed Abstract].
- Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre's syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012; 12: 808–15. [PubMed Abstract].
- Su CP, Huang PY, Yang CC, Lee MH. Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect. 2009; 42: 336–42. [PubMed Abstract].
- Epaulard O, Brion JP, Stahl JP, Colombe B, Maurin M. The changing pattern of Fusobacterium infections in humans: recent experience with Fusobacterium bacteraemia. Clin Microbiol Infec. 2006; 12: 178–81.
- Afra K, Laupland K, Leal J, Lloyd T, Gregson D. Incidence, risk factors, and outcomes of Fusobacterium species bacteremia. BMC Infect Dis. 2013; 13: 264. [PubMed Abstract] [PubMed CentralFull Text].
- Goldberg EA, Venkat-Ramani T, Hewit M, Bonilla HF. Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia. Epidemiol Infect. 2013; 141: 325–9. [PubMed Abstract].
- Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest. 1993; 103: 1502–7. [PubMed Abstract].
- Brims FJ, Lansley SM, Waterer GW, Lee YC. Empyema thoracis: new insights into an old disease. Eur Respir Rev. 2010; 19: 220–8. [PubMed Abstract].
- Justesen T. Anaerobic bacteria – with emphasize on culture and identification in laboratories of clinical microbiology. 2009. Available from: http://www.tagejustesen.dk/anaerobebakterier/ [cited 1 September 2015]..
- Sørensen HT. Prognosen efter akut indlæggelse på Medicinsk Visitationsafsnit på Nørrebrogade, Århus Sygehus. 2010; Århus Universitetshospital: Aarhus, Denmark: Klinisk Epidemiologisk Afdeling.
- Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, etal. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22: 299–306. [PubMed Abstract] [PubMed CentralFull Text].
- Seo SK. Infectious complications of lung cancer. Oncology (Williston Park). 2005; 19: 185–94. [PubMed Abstract] discussion 95–6, 99–203, 7–8.
- Khan SA, Wingard JR. Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr. 2001; 29: 31–6. [PubMed Abstract].
- Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VGJr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28: 603–61. doi: http://dx.doi.org/10.1128/CMR.00134-14 [PubMed Abstract].
- Kim HK, Thammavongsa V, Schneevind O, Missiakas D. Recurrent infections and immune evasion strategies of Staphylococcus aureus . Curr Opion Microbiol. 2012; 15: 92–9.
- Allen-Vercoe E, Strauss J, Chadee K. Fusobacterium nucleatum: an emerging gut pathogen?. Gut microbes. 2011; 2: 294–8. [PubMed Abstract].